- Goldenson, N. I., Shiffman, S., Sembower, M. A., et al. (2025). "Evaluating the Effect of the JUUL2 System With 5 Flavors on Cigarette Smoking and Tobacco Product Use Behaviors Among Adults Who Smoke Cigarettes: 6-Week Actual Use Study." Interactive Journal of Medical Research, 14, e60620. — PMC11982753 [Industry-funded: JUUL Labs]
- Large US JUUL cohort study (22,000+ participants, 2-year follow-up). "Menthol use was consistently associated with higher rates of complete switching." — PMC10552465
- Reynolds Science. "Measuring the Impact of Menthol and Tobacco-Flavored Vapor Product Use on Cigarette Smoking Cessation and Reductions: The Longitudinal Tobacco Use and Transitions Survey (LTTS)." — ReynoldsScience.com [Industry-funded: Reynolds]
- Randomized trial of menthol vs non-menthol e-cigarettes in Black and Latinx smokers. PMC. — PMC10246471
- Cardiovascular review (July 2026). "Full switch from smoking to vaping linked to lower heart risk." Published in Cureus. — PubMed 42389254; summary at Clearing the Air
- PMC. "Harm Reduction Implications of Vaping Overtaking Smoking in Great Britain." — PMC13083042
- Ling, P. M. & Glantz, S. A. (2026). "E-cigarettes increase harm and should be discouraged." Nature. — PDF
- Duke University. "A blind spot in e-cigarette research." Nicotine and Tobacco Research, 2025. — Duke Medicine
- Vaping Post. "Germany Proposes Ban on Menthol Vapes Despite Their Proven Effectivity for Smoking Cessation." February 4, 2026. — VapingPost.com
- FDA. "FDA Authorizes Marketing of JUUL2 E-Cigarette Device and Tobacco- and Menthol-Flavored Pods." August 28, 2026. — FDA.gov
- Clearing the Air. "Studies link vaping to lower death risk in cancer patients and reduced carcinogen exposure." — Clearing the Air
- 2025 US study on exclusive vaping and cardiovascular disease. Nicotine & Tobacco Research. — Oxford Academic
We Want to Hear From You
The menthol debate is one of the most contested topics in tobacco harm reduction. We want to know where you stand.
If menthol vapes help more adult smokers quit, should regulators prioritize adult access or youth prevention?
Open questions for the community:
- If you switched from smoking to vaping, which flavor did you use? Did the flavor matter for your success?
- The JUUL2 study was only 6 weeks long. Do you think 6-week switching rates predict long-term cessation? Why or why not?
- Canada saw cigarette sales rise ~10% after flavor bans. Does this change your view on flavor restrictions?
- The Glantz critique argues dual use is more harmful than exclusive smoking. Have you experienced the "dual use trap"? How did you break through it?
- Should the FDA require age-verification technology on all authorized menthol products, or is that overreach?
Want More Science Like This?
Subscribe to our newsletter for weekly harm reduction analysis, study breakdowns, and regulatory updates — delivered every Friday.
